Cho Myeonghoon, Park Byungkyu, Han Kyungsook
Department of Computer Engineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, Republic of Korea.
Research and Development Center, Hancom Carelink Incorporated, 49 Daewangpangyo-ro 644beon-gil, Bundang-gu, Seongnam, 13493, Gyeonggi-do, Republic of Korea.
Comput Biol Chem. 2025 Apr;115:108353. doi: 10.1016/j.compbiolchem.2025.108353. Epub 2025 Jan 16.
Cancer metastasis is the dissemination of tumor cells from the primary tumor site to other parts of the body via the lymph system or bloodstream. Metastasis is the leading cause of cancer associated death. Despite the significant advances in cancer research and treatment over the past decades, metastasis is not fully understood and difficult to predict in advance. In particular, distant metastasis is more difficult to predict than lymph node metastasis, which is the spread of cancer cells to nearby lymph nodes. Distant metastatic sites is even more difficult to predict than the occurrence of distant metastasis because the problem of predicting distant metastatic sites is a multi-class and multi-label classification problem; there are more than two classes for distant metastatic sites (bone, liver, lung, and other organs), and a single sample can have multiple labels for multiple metastatic sites. This paper presents a new method for predicting distant metastatic sites based on correlation changes of miRNAs with competing endogenous RNAs (ceRNAs) in individual cancer patients. Testing the method on independent datasets of several cancer types demonstrated a high prediction performance. In comparison of our method with other state of the art methods, our method showed a much better and more stable performance than the others. Our method can be used as useful aids in determining treatment options by predicting if and where metastasis will occur in cancer patients at early stages.
癌症转移是指肿瘤细胞从原发肿瘤部位通过淋巴系统或血液循环扩散到身体其他部位。转移是癌症相关死亡的主要原因。尽管在过去几十年里癌症研究和治疗取得了重大进展,但转移的机制仍未完全明确,且难以提前预测。特别是,远处转移比癌细胞扩散到附近淋巴结的淋巴结转移更难预测。预测远处转移部位比预测远处转移的发生更加困难,因为预测远处转移部位的问题是一个多类别、多标签的分类问题;远处转移部位有多个类别(骨、肝、肺和其他器官),且单个样本可能有多个转移部位的标签。本文提出了一种基于个体癌症患者中微小RNA(miRNA)与竞争性内源RNA(ceRNA)相关性变化来预测远处转移部位的新方法。在几种癌症类型的独立数据集上对该方法进行测试,结果显示其具有较高的预测性能。与其他现有方法相比,我们的方法表现出比其他方法更好、更稳定的性能。我们的方法可作为有用的辅助工具,通过预测癌症患者早期是否会发生转移以及转移的部位,来确定治疗方案。